老年颅脑损伤者术后血清和脑脊液NFL、GFAP对继发交通性脑积水的预测价值

doi:10.19854/j.cnki.1008-2425.2023.01.0009

摘要/Abstract

摘要： 目的研究老年颅脑损伤患者术后血清和脑脊液(CSF)神经丝蛋白轻链(NFL)、胶质纤维酸性蛋白(GFAP)对继发交通性脑积水的预测价值。方法回顾性分析2018年6月-2022年2月对我院神经外科收治的116例老年颅脑损伤患者,根据患者进行去骨瓣减压术和侧脑室外引流出院后至少随访6个月的临床诊断结果,将患者分为继发交通性脑积水组30例和非脑积水组86例。采集术后即刻、术后24h和48h引流的CSF,同时采集血清,采用酶联免疫分析法检测NFL、GFAP水平。结果 CSF NFL、GFAP水平存在时间、组别以及时间和组别交互作用(P＜0.05)。在术后即刻、术后24 h、48 h时,继发脑积水组CSF NFL、GFAP水平均高于非脑积水组(均P＜0.05);而且与术后即刻相比,随着EVD引流时间的延长,CSF NFL、GFAP水平逐渐降低(均P＜0.05)。经多因素Logistic回归分析,术后即刻CSF NFL、GFAP是影响老年颅脑损伤患者术后继发交通性脑积水的独立危险因素(P＜0.05)。此外,术后即刻血清和CSF中NFL、GFAP水平均呈正相关性(r=0.669,0.797,P＜0.001)。以非脑积水组作为对照,经受试者工作特征曲线分析,术后血清NFL+GFAP或CSF NFL+GFAP预测老年颅脑损伤者术后继发交通性脑积水的AUC分别为0.910(95%CI:0.856~0.964)、0.966(95%CI:0.937~0.994)。结论检测术后即刻血清和CSF中NFL、GFAP水平可以有效地预测老年颅脑损伤者去骨瓣减压术后继发交通性脑积水的发生风险。

关键词: 颅脑损伤, 神经丝蛋白轻链, 胶质纤维酸性蛋白, 继发交通性脑积水

Abstract: Objective To study the predictive value of serum and cerebrospinal fluid (CSF) neurofilament light chain (NFL) and glial fibrillary acidic protein (GFAP) in elderly patients with traumatic brain injury (TBI) after surgery.Methods A retrospective analysis of 116 cases of craniocerebral injury elderly patients admitted to our hospital from April 2018 to February 2020.According to the clinical diagnosis results of at least 6 months of follow-up after decompressive craniectomy and external ventricular drainage (EVD),the patients were divided into 30 cases of secondary communicating hydrocephalus group and 86 cases of non-hydrocephalus group.CSF drained immediately,24h and 48h after operation were collected,and serum at the same time were also collected.NFL and GFAP levels were analyzed by enzyme-linked immunoassay.Results CSF NFL and GFAP levels existed for time,group and interaction between time and group (P＜0.05).The levels of CSF NFL and GFAP in the secondary hydrocephalus group were higher than those in the non hydrocephalus group immediately,24h and 48h after operation (all P＜0.05);compared with immediately after operation,with the prolongation of EVD drainage time,the levels of CSF NFL and GFAP decreased gradually (all P＜0.05).Multiple Logistic regression analysis showed CSF NFL and GFAP immediately after surgery were the independent risk factors for the development of communicating hydrocephalus in elderly patients with traumatic brain injury (P＜0.05).Besides,there was a positive correlation between serum and CSF NFL and GFAP levels immediately after surgery (r=0.669,0.797,P＜0.001).With the non-hydrocephalus group as a control,after ROC curve analysis,the area of the receiver operating characteristic curve for the serum NFL+GFAP or CSF NFL+GFAP immediately after surgery predicted postoperative hydrocephalus were 0.910 (95%CI:0.856～0.964) and 0.966 (95%CI:0.937～0.994).Conclusion Detection of NFL and GFAP levels in serum and CSF immediately after operation can effectively predict the risk of secondary communicating hydrocephalus in elderly patients with craniocerebral injury after decompressive craniectomy.

Key words: Traumatic brain injury, Neurofilament light chain, Glial fibrillary acidic protein, Secondary communicating hydrocephalus

中图分类号:

R742.7

张爱军, 鲁友明, 陈鑫, 袁磊, 邹冬冬. 老年颅脑损伤者术后血清和脑脊液NFL、GFAP对继发交通性脑积水的预测价值[J]. 立体定向和功能性神经外科杂志, 2023, 36(1): 48-54.

Zhang Aijun, Lu Youming, Chen Xin, et al. Predictive value of postoperative serum and cerebrospinal fluid NFL and GFAP in elderly patients with traumatic brain injury on secondary communicating hydrocephalus[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2023, 36(1): 48-54.

参考文献

[1] 金陆昊,孙晓阳.去骨瓣减压术后颅骨缺损合并早期脑积水的发生机制及手术治疗研究进展[J].医学综述,2020,26(23):4704~4709.
[2] 孙硕,周辉,施辉.颅脑外伤后脑积水的发生及相关危险因素的研究进展[J].医学综述,2018,24(9):1739~1742,1748.
[3] Thelin EP,Zeiler FA,Ercole A,et al.Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics:A Systematic Review[J].Front Neurol,2017,8:300.
[4] Milhorat TH.Acute hydrocephalus[J].N Engl J Med,1970,283(16):857~859.
[5] Krejĉí O,Krejĉí T,Lipina R.Posttraumatic hydrocephalus[J].Rozhl Chir,2018,97(6):258~261.
[6] Ding J,Guo Y,Tian H.The influence of decompressive craniectomy on the development of hydrocephalus:a review[J].Arq Neuropsiquiatr,2014,72(9):715~720.
[7] 卢敏,彭希哲.基于期望余寿理论的老年定义新思考与中国人口态势重新测算[J].人口学刊,2018,40(4):5~18.
[8] Hawryluk GWJ,Rubiano AM,Totten AM,et al.Guidelines for the management of severe traumatic brain injury:2020 update of the decompressive craniectomy recommendations[J].Neurosurgery,2020,87(3):427~434.
[9] Carney N,Totten AM,O'Reilly C,et al.Guidelines for the management of severe traumatic brain injury,Fourth Edition[J].Neurosurgery,2017,80(1):6~15.
[10] Takagi K,Watahiki R,Machida T,et al.Reliability and interobserver variability of evans' index and disproportionately enlarged subarachnoid space hydrocephalus as diagnostic criteria for idiopathic normal pressure hydrocephalus[J].Asian Journal of Neurosurgery,2020,15(1):107~112.
[11] Kwah LK,Diong J.National Institutes of Health Stroke Scale (NIHSS)[J].J Physiother,2014,60(1):61.
[12] 郑维涛,高强,熊东胜.重型颅脑损伤患者术后脑积水的相关因素分析[J].中国临床医生杂志,2018,46(6):711~713.
[13] 王立江,元小冬.有创颅内压监测技术在重型颅脑损伤患者中的应用价值[J].解放军医药杂志,2017,29(8):55~59.
[14] 杨勇,曹作为,韦迪岱,等.CT脑脊液/脑内室体积与颅脑损伤颅内压及继发性脑损害的关系[J].广东医学,2018,39(15):2342~2344.
[15] 辛娜.丙泊酚持续静脉输注治疗外伤性重症颅脑损伤患者手术后脑水肿疗效观察[J].世界最新医学信息文摘(连续型电子期刊),2018,18(93):102,109.
[16] 杜勇,王革生,王雷,等.去骨瓣减压术治疗创伤性颅脑损伤术后并发症发生情况及危险因素分析[J].解放军医药杂志,2017,29(7):41~43+53.
[17] 陈昌,吴章泽,王一芳,王正伟.可调压分流管腰大池腹腔分流术治疗创伤后脑积水的临床疗效及对远期预后的影响[J].中西医结合心脑血管病杂志,2020,18(21):3688~3691.
[18] 曹轲,刘玉飞,钱振,等.重型和特重型颅脑损伤患者术后继发性脑积水的影响因素分析[J].中华神经外科杂志,2016,32(6):584~588.
[19] 李龙,杨金庆,薛勇,等.颅脑损伤去骨瓣减压术后脑积水危险因素分析及分流时机[J].中国临床神经外科杂志,2020,25(9):600~602.
[20] 黄贤键,吴楚伟,邹隽风,等.创伤性脑损伤后脑积水发生的危险因素分析[J].中华创伤杂志,2019,35(3):216~220.
[21] 潘庭荣,黄梅,潘丹丹,等.脑卒中患者Hcy、GFAP、BDNF和hs-CRP水平与血管性认知障碍相关性研究[J].东南大学学报(医学版),2018,37(4):648~652.
[22] 章显宝,何玲,王震,等.针刺对卒中后抑郁大鼠行为学及海马、皮质、杏仁核中 BDNF、GFAP表达水平的影响[J].北京中医药大学学报,2019,42(11):954~962.
[23] 徐昊,王占祥,张绍林,等.反应性胶质细胞增生、神经炎症与脑积水关系的实验研究[J].中华小儿外科杂志,2013,34(12):927~932.
[24] Shahim P,Politis A,Merwe Andre,et al.Time course and diagnostic utility of NfL,tau,GFAP,and UCH-L1 in subacute and chronic TBI[J].Neurology,2020,95(6):e623~e636.
[25] Benatar M,Zhang L,Wang L,et al.Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS[J].Neurology,2020,95(1):e59~e69.